Table 2.
Qualitative Values of Benign and Malignant Soft Tissue Tumors
| Benign | Malignant | p-value | ||
|---|---|---|---|---|
| Gender | Male | 34 (51.5%) | 25 (56.8%) | 0.585 |
| Female | 32 (48.5%) | 19 (43.2%) | ||
| T1W intensity | Hyperintensity | 37 (56.1%) | 6 (13.6%) | 0.000* |
| Iso/hypointensity | 29 (39.1%) | 38 (86.4%) | ||
| T2W intensity | Hypointensity | 7 (10.6%) | 15 (34.1%) | 0.003* |
| Iso/hyperintensity | 59 (89.4%) | 29 (65.9%) | ||
| Cyst | + | 2 (3.0%) | 10 (22.7%) | 0.003* |
| − | 64 (97.0%) | 34 (77.3%) | ||
| Necrosis | + | 0 (0.0%) | 27 (61.4%) | 0.000* |
| − | 66 (100%) | 17 (38.6%) | ||
| Calcification | + | 10 (15.2%) | 2 (4.5%) | 0.119 |
| − | 56 (84.8%) | 42 (95.5%) | ||
| Fibrosis | + | 7 (10.6%) | 12 (27.3%) | 0.023* |
| − | 59 (89.4%) | 32 (72.7%) | ||
| Hemorrhage | + | 0 (0%) | 9 (20.5%) | 0.000* |
| − | 66 (100%) | 35 (79.5%) | ||
| Septation | + | 25 (37.9%) | 19 (43.2%) | 0.578 |
| − | 41 (62.1%) | 25 (56.8%) | ||
| Lobulation | + | 17 (25.8%) | 33 (75%) | 0.000* |
| − | 49 (74.2%) | 11 (25.0%) | ||
| Border | Ill-defined | 6 (9.1%) | 26 (59.1%) | 0.000* |
| Well-defined | 60 (90.9%) | 18 (40.9%) | ||
| Peritumoral edema | + | 6 (9.2%) | 30 (68.2%) | 0.000* |
| − | 59 (67.0%) | 14 (31.8%) | ||
| Bone involvement | + | 4 (6.1%) | 7 (15.9%) | 0.112 |
| − | 62 (93.9%) | 37 (84.1%) | ||
| Vessel involvement | + | 1 (1.5%) | 10 (22.7%) | 0.000* |
| − | 65 (98.5%) | 34 (77.3%) | ||
| Enhancement post contrast | Heterogeneous | 20 (30.3%) | 34 (77.3%) | 0000* |
| No enhancement/ homogenous | 46 (69.7%) | 10 (22.7%) |
Notes: *Statistically significant difference between benign and malignant lesions. (+): present, (-): absent.